2Lev S, Moreno H, Martinez R, et al. Protein tyrosine kinase Pyk2 involved in Ca^2+ -induced regulation of ion channel and MAP kinase function[ J]. Nature, 1995, 376:737 -747
3Sasaki H, Nagura K, Ishino M, et al. Cloning and characterization of cell-adhesion kinase beta, a novel protein-tyrosine kinase of the focal adhesion kinase subfamily[J]. J Biol Chem, 1995, 270:21206-21219
4Dikic I, Tokiwa G, Lev S, et al. A role for Pyk2 and Src in linking G-protein-coupled receptors with Map kinase activation[ J ]. Nature,1996, 383:547 -550
5Tokiwa G, Dikic I, Lev S, et al. Activation of Pyk2 by stress signals and coupling with JNK signaling pathway[ J]. Science, 1996, 273:792 - 794
6Schlaepfer DD, Hauck CR, Sieg DJ, et al. Signaling through focal adhesion kinase[J]. Progress in Biophysics & Molecular Biology,1999, 71: 435 -478
7Matsuya M, Sasaki H, Aoto H, et al. Cell adhesion kinase beta forms a complex with a new member, Hic-5, of protein localized at focal adhesions[ J]. J Biol Chem, 1998, 273:1003 -1014
8Pei L, Li Y, Yan JZ, et al. Changes and mechanisms of proteintyrosine kinase and protein-tyrosine phosphatase activities after brain ischemia/reperfusion[J]. Acta Pharmacol Sin, 2000, 21 : 715 -720
9Liu Y, Zhang G, Gao C, et al. NMDA receptor activation results in tyrosine phosphorylation of NMDA receptor subunit 2A(NR2A) and interaction of Pyk2 and Src with NR2A after transient cerebral ischemia and reperfusion[J] . Brain Res, 2001, 909:51 -58
10Takagi C, Ueki K, Ikeuchi H, et al. Increased expression of cell adhesion kinase beta in human and rat crescentic glomerulonephritis[J]. Am J Kidney Dis, 2002, 39:174-182
1Mitra S K, Hanson D A, Schlaepfer D D. Focal adhesion ki- nase: in command and control of cell motilityEJ]. Nature Re- views Molecular Cell Biology, 2005, 6(1) : 56.
2Chatzizacharias N A, Kouraklis G P, Theocharis S E. Clinical significance of FAK expression in human neoplasia[J ]. Histol Histopathol, 2008, 23(5): 629.
3Chatzizacharias N A, Kouraklis G P, Theocharis S E. Clinical significance of FAK expression in human neoplasia[J]. Histol Histopathol, 2008, 23(5): 629.
4Ponnusamy M P, Singh A P, Jain M, et al. MUCA activates HER2 signalling and enhances the motility of human ovarian- cancer cells[J]. Br J Cancer, 2008, 99(3) : 520.
5Miyazaki T, Kat o H, Nakajima M, et al. FAK over expres- sionis correlated with tumour invasiveness and lymphnode metastasis in esophageal squamous cell carcinom a [ J ]. Br J Cancer, 2003, 89(1): 140.
6Golubovskaya VM. Focal adhesion kinase as a cancer therapy target[ J ]. Anticancer Agents Med Chem, 2010, 10 ( 10 ) : 735 - 741.
7Eleniste PP, Bruzzanit A. Focal adhesion kinase in adhesion structures and disease[J]. J Signal Trans,2012,5:1155 - 1167.
8Chen JS, Huang XH, Wang Q, et al. FAK is involved in invasion and metastasis of hepatocellular carcinoma[J]. Clin Exp Metastasis, 2010,27 (2) :71 - 82.
9Ashton GH, Morton JP, Myant K, et al. Focal adhesion kinase is required for intestinal regeneration and tumorigenesis downstream of Wnt/c-Myc signaling[J]. Developmental Cell,2010,19 ( 2 ) :259 -269.
10Liotta LA. Tumor invasion and metastases-role of the extracellular matrix [ J ]. Cancer Res, 1986,46 ( 1 ) : 1 - 7.
